The direct effect of GLP-1 receptor agonists on human hair follicles remains one of the most intriguing unanswered questions in dermatological pharmacology
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: a retrospective analysis of the diabetes prospective follow-up registry
Medicaid could start as early as May 2026, with Medicare Part D following in January 2027
CBDA exemplifies the nuanced pharmacology of minor cannabinoids and underscores the importance of the plants natural chemical architecture: 1
42.75 Retatrutide , commonly shortened to Reta, is available in batch-specific research quantities from 10mg to 60mg
On the Medicaid side, CMS launched the BALANCE model in December 2025, a voluntary five-year program for state agencies